Insilico Medicine plans a $1 billion China hub for AI drug discovery. Analysis of why China appeals, how AI speeds discovery, and the global implications for biotech.
Insilico Medicine’s $1 Billion Bet on China: What It Means for AI Drug Discovery Read More »
How AI is reshaping healthcare enterprise networks: diagnostics, operational automation, data-sharing models, patient outcomes, governance and what leaders should watch next.
AI in Healthcare Enterprise Networks: Scaling Care Through Data and Collaboration Read More »
AI demand forecasting is helping NHS A&E departments reduce waits, improve staffing and accelerate the NHS digital transformation under the Prime Minister’s AI Exemplars programme.
AI Transforms UK Emergency Care: How Predictive Analytics Is Easing A&E Pressure Read More »
A concise, objective review of AI reliability in medical diagnosis: where it excels, its main limitations, and how clinicians and AI can work together safely.
AI Diagnostics: A Balanced Look at Reliability Read More »
A concise assessment of AI’s diagnostic strengths in imaging and telehealth, the main reliability limits, and why clinician oversight remains essential.
AI in Healthcare Diagnosis: Promise, Limits, and the Case for Human Oversight Read More »
PreciseDx joins industry leaders at the NYC Leadership Summit to discuss AI-driven drug discovery, PreciseBreast, and the balance between innovation and regulation.
A concise AI-focused analysis of recent UK health developments and what they mean for AI adoption across the NHS, workforce and patient access.
UK Healthcare Trends: An AI Insider’s Perspective on the NHS 10-Year Plan Read More »
Discover how AI and biotechnology together drive sustainable food production, unlock revenue in alternative proteins and precision fermentation, and optimize supply chains.
How AI and Biotech Are Powering New Growth in the Food Industry Read More »
Explore how AI is intersecting with UK clinical trials, diagnostics and digital triage to relieve A&E pressure and accelerate NHS innovation.
How AI Is Shaping UK Healthcare: From Liver Trials to Smarter A&E Pathways Read More »
AI models in cancer pathology can learn patient demographics from slides, producing unequal diagnostic performance. FAIR-Path uses contrastive learning to cut disparities by ~88%.
Unmasking Demographic Bias in AI Cancer Pathology and the FAIR-Path Solution Read More »
